-
Seems
$GILD has missed the boat.$Cydy. Gilead's Achilles' Heel - HIV Franchise In Serious Jeopardy$GILDhttps://seekingalpha.com/article/4321216 -
$CYDY CytoDyn files Phase 2 basket trial with lead drug leronlimab for treating all solid cancer tumors http://tinyurl.com/rwak6fw via@proactive_NA@CytoDyn#CYDY -
$CYDY#OTCQB CytoDyn Inc. (CYDY: OTCQB) | CytoDyn Files a Phase 2 Basket Trial with Leronlimab (PRO 140) for Treatment of All Solid Tumor Cancershttp://dlvr.it/RPVStt -
-
$NAFS Announces $4.5 Million in Revenues in 2019 Fiscal Year https://finance.yahoo.com/news/nafs-voycare-announces-4-5-133000264.html …$PURA$UOIP$KICK$SPRV$HUGE$RSHN$HHSE$NBDR$ACNNF$USMJ$PHGUF$WISH$ARGQ$CHSH$KGKG$LEAS$DAVC$LRSV$ONCI$ITCC$NWBO$SRHIF$CYDY$CRWG$PWDYpic.twitter.com/4za3ab41kc
-
Your take presently on
$CYDY ? -
$CUBV.0006 - No DILUTION - No NOTES - No DEBTS - 59 Filings... Now you know! Clean Shell!$HDII$MCTC$SNWV$DMAN$RMSL$TNEN$BZTG$IRNC$ACCR$PTAH$AGRX$INKW$KYNC$ZDEC$ALPP$CRDL$XSPT$CYDY$SAML$NDYN$SOAN$APRO$PFMS$DCSR$IGEX$CNNA$DLCR$GRNF$FERN$DLYT$BIPHpic.twitter.com/XJzzNcacXE
-
Short
$CYDY avg ~$1.44. Data on *3* subjects clearly confounded by coadministration of carboplatin, and so anything but “stunning” (their word). And of course the empty nCoV hype. Should fade back to $0.50 in a little while. -
$CYDY issues PR's routinely but hides via 8K selling stock at extreme discount to current price. Raised $7.57M gross $ 1/31/20 @ $1.00/share w/ warrants to purchase 3,785M shares @ a buck. And they rec dividends 10% per share. Such a deal for insiders. https://bit.ly/2Sf6OLi -
CEORoadshow Interviews CEO of Late Stage Biotech, CytoDyn, (CYDY) http://ceoroadshow.com/ceoroadshow-interviews-ceo-of-late-stage-biotech-cytodyn-cydy/ … via
@CEORoadShow$CYDY All good things!!! -
$CYDY Status on: BLA for HIV Coronavirus in China Cancer Trials Bruce Patterson and CEO will preside. https://twitter.com/StockTexts/status/1224399890429677569 … -
-
$CYDY Busting out, 40% increase on DAX market prior to U.S market open..... https://wertpapiere.ing.de/Investieren/Aktie/Boersen/US23283M1018 …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.





/
LOOPShare Announces Launch of Scoot-E-Bike(R) Retail Website